France · Question · Question écrite
17020
Question 17020 — human blood and organs
Introduced
14 July 2026
Last action
—
Status
posée
Sponsors
—
Subjects
Discovery layer
Source updated
14 July 2026
Summary
Mr. Eric Liégeon draws the attention of the Minister of Health, Families, Autonomy and Disabled People to plasma donation in France and the need to develop the practice much more widely. The majority component of blood, plasma is used to manufacture drugs essential for the treatment of thousands of patients suffering from immune deficiencies, neurological, hematological or autoimmune diseases. However, plasma donations in France are today largely insufficient and the country remains heavily dependent on foreign imports to cover its needs. France thus depends more than 60% on the United States of America for the manufacture of plasma-derived medicines (PDM). In an opinion published in January 2024, the National Consultative Ethics Committee (CCNE) also underlined the urgency of responding to the growing dependence on France in this area. Faced with this situation, the public authorities have entrusted the EFS with the “Ambition Plasma” program, the objective of which is to reach 1.4 million liters of plasma collected annually by 2028 in order to strengthen the country's health autonomy. The success of this ambition therefore requires unprecedented national mobilization and massive citizen awareness, in particular through awareness campaigns. communication, so that more of them can give. Plasma donation thus becomes a major public health and health sovereignty issue. This is why recognizing plasma donation as a Great National Cause 2027 could enable this essential awareness. Indeed, the award of this label would constitute a powerful lever for raising awareness among the general public thanks to the dissemination of national campaigns aimed at encourage donations and a strong signal from the State in favor of French health sovereignty. It would also be a concrete response to the growing needs of patients (+ 8% per year) dependent on drugs derived from plasma. The objective is clear: save lives while strengthening the country's health independence. Consequently, he asks her what measures she intends to take to make plasma donation more attractive. among the French population and to strengthen France's health independence on this subject. He would like to know if she therefore intends to make it a Great National Cause for 2027.
Machine translation from French. The official text remains authoritative.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.assemblee-nationale.fr/dyn/17/questions/QANR5L17QE17020
- Open data entity: https://www.assemblee-nationale.fr/dyn/opendata/QANR5L17QE17020